Saturday, November 21, 2009
Print Current Day:
|
|
SESSION 29 SCHEDULE | |
Saturday
SESSION 29:
NEW DEVELOPMENTS IN THE TREATMENT OF AAAS: EVAR, OPEN REPAIR, LAPAROSCOPIC AND ROBOTIC REPAIR (5-MINUTE TALKS)
xxxx
Moderators:TBD
|
|
x | |
6:40 AM - 6:45 AM | State-of-the-Art In Protecting Renal Function With Angiographic Procedures That Require Contrast |
6:46 AM - 6:51 AM | Endovascular Repair Of Mycotic Aneurysms: Should It Be First-Line Therapy? |
6:52 AM - 6:57 AM | Tips And Tricks For Doing Hybrid Procedures For Thoracoabdominal Aneurysms Successfully And With Less Morbidity |
6:58 AM - 7:03 AM | Off-the-Shelf Balloon Expandable Stent-Graft Can Replace Many Fenestrated Grafts With Juxtarenal AAAs And Others With “Impossible Necks” |
Presenters(s):Ralf R. Kolvenbach, MD | |
7:04 AM - 7:09 AM | Changes In Patient Fitness And EVAR Suitability During Surveillance Of Small AAAs: When Should Small AAAs Have Early Repair? |
7:10 AM - 7:15 AM | Results From The PIVOTAL Trial Comparing Observation And EVAR For Small AAAs |
7:16 AM - 7:21 AM | Results From The CAESAR Trial Comparing Observation With EVAR For Small AAAs |
7:22 AM - 7:31 AM | Panel Discussion |
Moderator(s): TBD / TBD | |
7:31 AM - 7:41 AM | What Are The Limits Of Laparoscopic AAA Repair: When Is It Superior To EVAR: Is It Applicable To Juxta- And Pararenal AAAs? (10-Minute Talk) |
7:42 AM - 7:47 AM | Robotic Aortic Surgery: What Is Needed To Make It Work And What Is Its Future In The Endovascular Era? |
7:48 AM - 7:53 AM | Standard Open Repair Is Still The Preferred Treatment For AAA In Good And Moderate Risk Patients |
7:54 AM - 7:59 AM | Glasgow Aneurysm Score For Risk Estimation With Ruptured AAAs: What Is It And Is It Valid In The Endovascular Era: Is There A Better Method? |
8:00 AM - 8:05 AM | Debate 16: We Must Have A Trial With Ruptured AAAs Comparing Treatment With CT And EVAR When Possible To Open Repair (OR) |
8:06 AM - 8:11 AM | Debate 16: We Don’t Need A Randomized Trial Comparing OR And EVAR: If Done Right EVAR Is Clearly Better |
8:12 AM - 8:17 AM | Updated (2009) World Experience With EVAR For Ruptured AAAs: The Case That EVAR Is Better If The Anatomy Is Favorable |
8:18 AM - 8:26 AM | Panel Discussion |
END OF SESSION 29 | |
SESSION 30 SCHEDULE | |
Saturday
SESSION 30:
PROGRESS IN DISEASES OF THE AORTA AND ITS ABDOMINAL BRANCHES (5-MINUTE TALKS)
xxxx
Moderators:TBD
|
|
x | |
8:26 AM - 8:31 AM | Present Status Of Renal Stenting: Results Of Randomized Comparisons Of Bare Metal Stents With Drug Eluting Stents (DES) And Best Medical Therapy: The Present Role Of Therapeutic Stenting And Prophylactic Stenting |
8:32 AM - 8:37 AM | Role Of Statins In Renal Artery Stenosis: What Is The Current Role For Renal Stenting And Embolic Protection? |
8:38 AM - 8:43 AM | Will Improved Renal Stenting Systems (Lower Profile, Rapid Exchange, DES, etc.) Make A Difference In Outcomes? |
8:44 AM - 8:49 AM | Renal Artery Stenting Under Embolic Protection With The FIBERNET Filter Device |
8:50 AM - 8:55 AM | Left Retroperitoneal Approach For Right Renal Artery Bypass |
8:56 AM - 9:01 AM | Treatment Of Renal Artery Aneurysms: Open Operation, Endovascular Treatments, Observation: When, How, Techniques And Tools |
9:02 AM - 9:07 AM | Panel Discussion |
Moderator(s): TBD / TBD | |
9:08 AM - 9:13 AM | Current Treatment For Mid-Aortic Pararenal Coarctation: Is There A Role For Endovascular Treatment? |
9:14 AM - 9:19 AM | Is PTA And Stenting Safe For Classic Descending Aortic Coarctation: What Precautions Must Be Taken To Assure Safety: Is Open Surgery Ever Needed? |
Presenters(s):Christoph A. Nienaber, MD, PhD | |
9:20 AM - 9:25 AM | Stenting For Aortic Bifurcation Disease: Hugging Is Better Than Kissing |
9:26 AM - 9:31 AM | Technical Tips And Tricks For Visceral Artery Stenting |
9:32 AM - 9:37 AM | Treatment Of Visceral Artery Occlusive Disease: Are The Days Of Open Surgery Over? |
9:38 AM - 9:43 AM | Indications And Optimal Treatment For Visceral Artery Aneurysms: Lessons Learned From 200 Cases |
9:44 AM - 9:52 AM | Panel Discussion |
END OF SESSION 30 | |
SESSION 31 SCHEDULE | |
Saturday
SESSION 31:
THE FUTURE, ISSUES, CONCEPTS AND INTERACTION WITH GOVERNMENT (5-MINUTE TALKS)
xxxx
Moderators:TBD
|
|
x | |
9:52 AM - 9:57 AM | A Look To The Future Of Vascular Disease Treatment |
Presenters(s):Edward B. Diethrich, MD | |
9:58 AM - 10:03 AM | New Products For Improved Endografting From Cook: Is There Anything For Type A Aortic Dissection? |
Presenters(s):Matt M. Thompson, MD | |
10:04 AM - 10:09 AM | Next Generation Devices For TEVAR: What’s In The Pipeline? |
10:10 AM - 10:15 AM | Why Are Drug Eluting Balloons Going To Work? |
10:16 AM - 10:21 AM | Burning Bridges With Endovascular Treatment: Does Aggressive Endovascular Therapy Lead To More Costly And Inferior Results For Some Patients: How Can We Be More Selective? |
10:22 AM - 10:27 AM | Increasing Mortality With Decreasing Number Of Patients Treated In A Given Hospital: Should There Be More Regionalization: Will It Decrease Costs? |
10:28 AM - 10:33 AM | Debate 17: Regulatory Procedures Are Necessary To Protect Patient Safety Even If They Inhibit Innovation Somewhat: The Status Quo In The U.S. Is Good |
10:34 AM - 10:39 AM | Debate 17: Regulatory Procedures Inhibit Innovation Greatly And The Status Quo With Them In The U.S. Is Bad |
10:40 AM - 10:45 AM | What Will Be The Toll Of U.S. Government Actions On The Device Industry And The Economy: Will We Outsource This Industry Too? |
10:46 AM - 10:52 AM | Panel Discussion |
END OF SESSION 31 | |
SESSION 32 SCHEDULE | |
Saturday
SESSION 32:
A TRIBUTE TO OUR MILITARY (5-MINUTE TALKS)
xxxx
Moderators:TBD
|
|
x | |
10:52 AM - 10:54 AM | Introduction |
10:55 AM - 11:00 AM | Volunteer Vascular Surgery Program At Landstuhl Medical Center In Germany: A Civilian Perspective On Military Injuries |
11:01 AM - 11:06 AM | Use Of Prosthetic Grafts In Complex Vascular Trauma: An Altered New Limb Salvage Strategy For Patients With Limited Autologous Conduit |
11:07 AM - 11:12 AM | Surgical Response To Multiple Casualty Incidents From Single Explosive Events: Guidelines In The Modern Era |
11:12 AM - 11:15 AM | Questions And Answers |
END OF SESSION 32 | |
SESSION 33 SCHEDULE | |
Saturday
SESSION 33:
ISSUES RELATED TO BUSINESS, COSTS, SPECIALTY AND TRAINING (5-MINUTE TALKS)
xxxx
Moderators:TBD
|
|
x | |
11:15 AM - 11:20 AM | New Coding And Reimbursement Issues And Tips For 2009 And 2010 |
11:21 AM - 11:26 AM | What Impact Will Health Care Reform Have On Vascular Surgery This Year And Next? |
11:27 AM - 11:32 AM | What Changes And Improvements Are Happening With The JVS In 2009 And Beyond? |
11:33 AM - 11:38 AM | Cost Savings From A Duplex Only Strategy For EVAR Surveillance After The 30-Day CT Scan |
11:39 AM - 11:44 AM | Improved System For Simulator Based Training In A Simulated Hybrid Operating Room |
11:45 AM - 11:50 AM | How To Get Medical Students To Go Into A 0 And 5 Vascular Surgery Training Program |
11:51 AM - 11:56 AM | Vascular Surgery Training Now And In The Future |
11:57 AM - 12:02 PM | Ideal Training Program In Vascular Surgery: Does It Need General Surgery? |
12:03 PM - 12:09 PM | Panel Discussion |
END OF SESSION 33 | |
SESSION 34 SCHEDULE | |
Saturday
SESSION 34:
LUNCHEON SESSION ON NEW AND IMPROVED TECHNQUES, ENDOGRAFTS AND DEVICES (5-MINUTE TALKS)
xxxx
Moderators:Matt M. Thompson, MD
|
|
x | |
12:10 PM - 12:15 PM | Update On The ANACONDA Graft For EVAR: Advantages And Limitations |
12:16 PM - 12:21 PM | Status Of The ENDURANT AAA Stent-Graft In The U.S. |
12:22 PM - 12:27 PM | The EVITA Graft For EVAR: Advantages And Limitations |
12:28 PM - 12:33 PM | U.S. Experience With The AORFIX Endograft: (Lombard Medical): Advantages, Limitations And Status Of The U.S. Trial |
12:34 PM - 12:39 PM | Advantages, Limitations And Experience With The RELAY PLUS Thoracic Endograft (Bolton Medical) |
12:40 PM - 12:45 PM | Update On The Status Of The U.S. Trial With The APTUS Endograft With Staple Fixation: Advantages, Technique And Limitations |
12:46 PM - 12:51 PM | Update On The Improved POWERLINK Endograft With IntuiTrak From Endologix With The IntuiTrak Express Delivery System For Easier Deployment: How Does It Work; Advantages; Limitations |
12:52 PM - 12:57 PM | The Ever Shrinking Profile Of Devices For EVAR: When Does It Matter? The New ZENITH Low Profile Device From Cook |
12:58 PM - 1:03 PM | Are New And Better Stents Possible: By What Approaches? |
1:04 PM - 1:10 PM | Panel Discussion |
END OF SESSION 34 | |
SESSION 35 SCHEDULE | |
Saturday
SESSION 35:
ETHICS, STANDARDS, REGISTRIES, RELATIONS WITH INDUSTRY, MALPRACTICE ISSUES (5-MINUTE TALKS)
xxxx
Moderators:TBD
|
|
x | |
1:10 PM - 1:15 PM | What Is Happening To The Relationship Between Physicians, Industry And CME: Is Government And The ACCME Going To Block Industry Support For CME Activities? |
1:16 PM - 1:21 PM | Debate 18: Off-Label Use Of Devices By Physicians Is Acceptable: It Facilitates Patient Treatment |
1:22 PM - 1:27 PM | Debate 18: Off-Label Use Of Devices Is Not Acceptable In Most Instances: Reasons Why |
1:28 PM - 1:33 PM | Little Known Risks Of Hospital Or Institutional Malpractice Insurance Coverage |
1:34 PM - 1:39 PM | Randomized Controlled Trials With Patient Groups Or Arms Getting No Treatment Or Observation Are Inherently Flawed: Why And What Can Be Done About It? |
1:40 PM - 1:45 PM | Should We Have Reporting Standards For Endovascular Interventions: How Will We Get Them? |
1:46 PM - 1:51 PM | Evolution Of The Northern New England Vascular Registry: New Information Regarding AAA Repair And Carotid Endarterectomy |
1:52 PM - 2:00 PM | Panel Discussion |
END OF SESSION 35 | |
SESSION 36 SCHEDULE | |
Saturday
SESSION 36:
VASCULAR DISEASE NATURAL HISTORY, MEDICAL TREATMENTS AND PREVENTION, AND TREATMENT OF COMPLICATIONS (5-MINUTE TALKS)
xxxx
Moderators:TBD
|
|
x | |
2:00 PM - 2:05 PM | Long-Term Cardiac Outcomes Of High Risk AAA Patients After EVAR And OR |
2:06 PM - 2:11 PM | Does The Presence Of An AAA Protect Against Stroke: Why Is This So? |
2:12 PM - 2:17 PM | Hybrid Technique To Treat Infected Vascular Grafts With An Endograft, Drainage And A VAC Dressing: When Can They Work? |
2:18 PM - 2:23 PM | Pharmacologic Approaches To Spinal Cord Protection |
2:24 PM - 2:29 PM | What Technical Maneuvers Can Help The CAS Operator Deal With Inability To Retrieve Filters, No Flow Through The Filter, Heavily Calcified Lesions And Intolerance To Flow Arrest |
2:30 PM - 2:35 PM | Innovative Endovascular Treatments Of Complex Failures Of Previous EVAR Procedures: These Bailouts Include Use Of Fenestrated Cuffs |
2:36 PM - 2:41 PM | Tips And Tricks To Allow Endovascular Treatment Of Complex Limb Disconnects After EVAR |
2:42 PM - 2:47 PM | Iron Stores, Inflammation And Biomarkers: How Do They Influence Atherosclerosis: Do Statins Help? |
2:48 PM - 2:53 PM | Technical Tips On The Use Of ONYX In The Treatment Of Type II Endoleaks |
2:54 PM - 3:08 PM | Panel Discussion |
END OF SESSION 36 | |
SESSION 37 SCHEDULE | |
Saturday
SESSION 37:
UPDATES AND NEW TECHNIQUES (4-MINUTE FAST-PACED TALKS)
xxxx
Moderators:TBD
|
|
x | |
3:08 PM - 3:12 PM | How To Predict AAA Rupture By Looking At Wall Stress, Wall Strength And Extent Of Intraluminal Thrombus |
3:13 PM - 3:17 PM | With TEVAR What Is The Best Way To Decrease Flow And Minimize Migration During Deployment: The Myth Of Lowering BP For Deployment Of Thoracic Endografts |
3:18 PM - 3:22 PM | Exceptional Way To Treat Infected Aneurysmal Sac Due To Aorto-Esophageal Fistula |
3:23 PM - 3:27 PM | What Is The Role Of A Flexible Kink-Resistant Stent-Graft:7-Year Clinial Experience With The AORFIX Aortic Endograft For AAAs |
3:28 PM - 3:32 PM | Debate 19: No Patient Should Undergo CAS Without Embolic Protection |
3:33 PM - 3:37 PM | Debate 19: There Are Patients Who Should Undergo CAS Without Embolic Protection |
3:38 PM - 3:42 PM | The FDA's Current Position On Embolic Protection Devices During CAS |
3:43 PM - 3:47 PM | New Simplified Sutureless Device For End-to-Side Aortic Anastomoses |
3:48 PM - 3:52 PM | The Un-Balloon Non-Occlusive Modeling Catheter: A Better Answer To Aortic Stent-Graft Forced Expansion For Modeling |
3:53 PM - 3:57 PM | How Best To Revascularize Occluded Mesenteric Artery: When Is PTA And Stenting Safe, And When Is Open Surgery Best Based On A Large Clinical Experience? |
3:58 PM - 4:04 PM | Panel Discussion |
Moderator(s): TBD / TBD | |
4:04 PM - 4:08 PM | How To Create A Hybrid Operating Room |
4:09 PM - 4:13 PM | Optimal Sequence And Staging For Patients Who Need Coronary And Carotid Procedures (CAS or CEA) |
4:14 PM - 4:18 PM | When Is Laparoscopic Treatment Of Type II Endoleaks Required: What Are The Technical Requirements: How Much Laparoscopic Experience Is Needed? |
4:19 PM - 4:23 PM | Celiac Artery Coverage During TEVAR Is Safe Acutely And Midterm: When Should It Be Avoided? |
4:24 PM - 4:28 PM | Errors In Determining AAA Diameter With Ultrasound Compared To 3-D CTA: Its Importance In Evaluating The ADAM And UK Small Aneurysm Trials |
Presenters(s):Timothy A. Resch, MD, PhD | |
4:29 PM - 4:33 PM | Do TEVAR Outcomes Differ For Acute And Chronic Type B Aortic Dissections And Why? |
4:34 PM - 4:38 PM | Indications For Statin In Patients Undergoing EVAR: When Should They Be Started And At What Dose? |
4:39 PM - 4:43 PM | Debate 20: Failed Endografts Requiring Open Surgery Usually Mandate Graft Removal: Tips For Doing This Safely |
4:44 PM - 4:48 PM | Debate 20: Open Surgical Salvage Of Failed Endograft Without Graft Removal Is Usually Possible: Technical Tips For Accomplishing This |
4:49 PM - 4:55 PM | Panel Discussion |
END OF SESSION 37 | |
SESSION 38 SCHEDULE | |
Saturday
SESSION 38:
MORE UPDATES AND NEW TECHNIQUES (5-MINUTE TALKS)
xxxx
Moderators:TBD
|
|
x | |
4:55 PM - 5:00 PM | Adverse Event Rates For CAS And CEA From The SVS Registry |
5:01 PM - 5:06 PM | Tips And Tricks For Anterior Exposure Of The Spine By Vascular Surgeons |
5:07 PM - 5:12 PM | Diagnosis And Treatment Of Arterial Aneurysms In Patients With Behçet Disease |
5:13 PM - 5:18 PM | Duplex Velocities Determine Need For CAS After CEA With Neurological Symptoms; Without Symptoms |
5:19 PM - 5:24 PM | Men And Women With AAAs Behave Differently And Different Guidelines Are Needed |
5:25 PM - 5:30 PM | 3-D CT Localization Of Artery Of Adamkiewitz: Is It Accurate? |
5:31 PM - 5:36 PM | Role Of Endovascular Techniques In Treatment Of Carotid Body Tumors |
5:37 PM - 5:43 PM | Panel Discussion |
Moderator(s): TBD / TBD | |
5:43 PM - 5:48 PM | The Bridge Graft With Vein And PTFE: A New Option For CLI With 15 Years Follow-up Showing Endothelialization Of The PTFE |
5:49 PM - 5:54 PM | Tips And Tricks For Intracranial Neuro Rescue During And After CAS |
5:55 PM - 6:00 PM | Simple Method To Measure Trans-Stenotic Pressure Gradient Accurately |
6:01 PM - 6:06 PM | How To Cool The Kidneys To Protect Them During Open Pararenal Aortic Surgery |
6:07 PM - 6:12 PM | Use Of Amplatz Septal Occluder For Gunshot Wound Of The Aorta |
6:13 PM - 6:18 PM | Advantages Of The TAArget Endograft For TEVAR: 3-Year Experience At A Single Center |
6:19 PM - 6:25 PM | Panel Discussion |
END OF SESSION 38 |